Point-of-Care Diagnostics Market Expected to Reach $77.8 Billion by 2028, Driven by Rising Disease Prevalence and Advances in Rapid Testing

• Point of Care Diagnostics market revenue was $49.7 billion in 2023 and is expected to reach $77.8 billion by 2028, growing at a 9.4% CAGR.

• Growth is driven by rising prevalence of infectious diseases and cardiovascular diseases, technological advancements in rapid tests, and decentralization of healthcare.

• By product, infectious disease testing PoC products will see significant growth due to the rise in diseases like COVID-19 and sexually transmitted infections.

• By sample, blood samples dominate the market due to widespread usage in testing for conditions like anemia, infectious diseases, and diabetes.

• Asia Pacific point of care diagnostics market will register significant growth due to expanding healthcare facilities and rising prevalence of diseases like diabetes and cardiovascular disease.